Status:
TERMINATED
A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Geographic Atrophy
Eligibility:
All Genders
50+ years
Phase:
PHASE3
Brief Summary
This study is a Phase III, double-masked, multicenter, randomized, sham injection-controlled study evaluating the efficacy and safety of lampalizumab administered by intravitreal injections in partici...
Eligibility Criteria
Inclusion
- Well demarcated area(s) of Geographic Atrophy (GA) secondary to Age-Related Macular Degeneration (AMD) with no evidence of prior or active choroidal neovascularization (CNV) in both eyes
Exclusion
- Ocular
Key Trial Info
Start Date :
September 18 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 29 2018
Estimated Enrollment :
906 Patients enrolled
Trial Details
Trial ID
NCT02247479
Start Date
September 18 2014
End Date
January 29 2018
Last Update
June 26 2019
Active Locations (145)
Enter a location and click search to find clinical trials sorted by distance.
1
Uni of Alabama At Birmingham Clinical Research Unit
Birmingham, Alabama, United States, 35233
2
Retinal Research Institute, LLC
Phoenix, Arizona, United States, 85014
3
Retina Centers P.C.
Tucson, Arizona, United States, 85704
4
California Retina Consultants
Bakersfield, California, United States, 93309